Paper ID:8428

Induction of Matrix Metalloproteinases in Chondrocytes by Interleukin IL1β as an Osteoarthritis Model

 Ervi Afifah1, Tjandrawati Mozef2, Ferry Sandra, Seila Arumwardana1, Dwi Davidson Rihibiha1, Hayatun Nufus1, Rizal Rizal1, Annisa Amalia1, Indra Bachtiar3, Harry Murti3 & Wahyu Widowati4

 1Biomolecular and Biomedical Research Center, Aretha Medika Utama, Bandung 40163, West Java, Indonesia
2Research Center for Chemistry, Indonesian Institute of Sciences, Serpong, Indonesia
3Stem Cell and Cancer Institute, Jakarta 13210, Indonesia
4Medical Research Center, Faculty of Medicine, Maranatha Christian University, Bandung 40164, West Java, Indonesia


Received September 25th, 2017, 1st Revision November 16th, 2017, Accept to Publish July 25th, 2018

Abstract. Osteoarthritis (OA) is a chronic disease on joint and bone due to trauma or other joint-related diseases (secondary). Synovial inflammation commonly causes disturbance in joint homeostasis which is associated with OA. Enzymes such as aggrecanase and metalloproteinease generate cartilage damage which is mediated by Interleukin (IL)-1 and Tumor Necrosis Factor (TNF). Pro-inflammatory cytokines, such as IL1β, TNF-α and IL-6, are responsible in regulation of extracelluler matrix, cartilage degradation, and apoptosis of chondrocyte. This study aimed to observe cell viability and level expression of matrix metalloproteinases (MMP1 and MMP3) and tissue inhibitor metalloproteinases (TIMP1 and TIMP2), in human chondrocyte cells (CHON002) induced by IL1β. CHON002 was induced with IL1β (0,1 ; 1 and 10 ng/ml) as an OA model. Viability was measured with a 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxyme-thoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS) assay, whilst expression of MMP1, MMP3, TIMP1, and TIMP2, was evaluated by RT-PCR. The viability of IL1β-induced CHON002 (CHON002- IL1β)  cells at day 1 and 5 showed that treatments with up to 10 ng/ml IL1β were not toxic. Expression of TIMP1 and TIMP2 in CHON-IL1β was lower compared to control, while that of MMP1 and MMP3 was higher compared to control. These results indicated that CHON002 treated with 10 ng/ml IL1β showed expression patterns consistent with chondrocyte damage, so the CHON-IL1β system may serve as a model for MMP induction in OA.

Keywords: metalloproteases, interleukin, mesenchymal stem cell, osteoarthritis, MMPs gene.


[1]          Ahmed U, Anwar A, Savage RS, Costa ML., Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health, Sci Reports. pp 1-7. 2015.

[2]          Courties A, Gualillo O, Berenbaum F, Sellam J., Metabolic stress-induced joint inflammation and osteoarthritis, OARS. 24 (2015), pp 1955-1965. 2015.

[3]          Noth U, Steinert, AF, Tuan RS, Technology Insight: adult mesenchymal stem cells for osteoarthritis therapy,  Nat Clin Pract Rheumatol, 4 (7), pp 371-80. 2008.

[4]          Cheng AWM, Satbler TV, Bolognesi M, Kraus VB., Selenomethionine Inhibits IL1β Inducible Nitric Oxide Synthase (iNOS) and Cyclooxygenase 2 (COX2) Expression in Primary Human Chondrocytes, OARS, 19 (1), pp 118-125. 2011.

[5]          Ozkan Y, Yardym-Akaydyn S, Sepici A., Oxidative status in rheumatoid arthritis, Clin Rheumatol. 26(1), pp 64-8. 2007.

[6]          Lu H, Jiang J, Xie G, Liu W, Yan G., Effects of an aqueous extract of Eucommia on articular cartilage in a rat model of osteoarthritis of the knee, Exp Ther Med, 6 (3), pp. 684-688. 2013.

[7]          Sokolove J, Lepus CM., Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations, Ther Adv Musculoskelet, 5 (2), pp. 77-94. 2013.

[8]          Rose BJ, Kooyman DL., A Tale of Two Joints: The Role of Matrix Metalloproteases in Cartilage Biology, Dis Markers, 2016 , pp.4895050. 2016.

[9]          Higashiyama R, Miyaki S, Yamashita S, Yoshitaka T, Lindman G, Ito Y, Sasho T, Takahashi K, Lotz M, Asahara H., Correlation between MMP-13 and HDAC7 expression in human knee osteoarthritis, Mod Rheumatol, 20 (1), pp.11. 2010.

[10]      Francis MS, Yates MP, Vickery LE, Klover JA, Song LRH, Anglin CP, Misko TP., Protein geranylgeranylation controls collagenase expression in osteoarthritic cartilage, OARS, 18 (2010), pp.948–955. 2010.

[11]      Tchetian EV, Kobayashi M, Yasuda T, Meijers T, Pidoux I, Poole AR., Chondrocyte hypertrophy can be induced by a cryptic sequence of type II collagen and is accompanied by the induction of MMP-13 and collagenase activity: Implications for development and arthritis, Matrix Biol. 26 (2007), pp.247–258. 2007.

[12]       Dejica VM, Mort JS, Laverty S, Antoniou J, Zukor DJ, Tanzer M, Poole AR., Increased type II collagen cleavage by cathepsin K and collagenase activities with aging and osteoarthritis in human articular cartilage, Arthritis Res Ther, 14, pp.113. 2012.

[13]      Brew K, Nagase H., The tissue inhibitors of metalloproteinases (TIMPs): An ancient family with structural and functional diversity, Biochim Biophys Acta, 1803(1), pp.55-71. 2010.

[14]      Goldring MB, Otero M., Inflammation in osteoarthritis, Curr Opin Rheumatol, 23 (5), pp.471–478. 2011.

[15]      Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier JP, Fahmi H., role of proinflammatory cytokines in the pathophysiology of osteoarthritis, Nat Rev Rheumatol, 7, pp.43–42. 2011.

[16]      Sellam J, Berenbaum F., the role of synovitis in pathophysiology and clinical symptoms of osteoarthritis, Nat Rev Rheumatol, 6, pp.625–635. 2010.

[17]      Haseeb A, Haqqi TM., Immunopathogenesis of osteoarthritis, Clin Immunol, 146, pp.185–196. 2013.

[18]      Tsuchiyaa, K., Chenb, B., Ushidac, T., Matsunoa, T., Tateishib., T. (2004). The effect of coculture of chondrocytes with mesenchymal stem cells on their cartilaginous phenotype in vitro.  Mater. Sci. 24 (3), pp. (391-396). 2014

[19]      Widowati, W., Wijaya, Laura; Wargasetia, Teresa L.; Bachtiar, Indra; Yellianty, Yellianty; Laksmitawati, Dian R., Antioxidant, anticancer, and apoptosis-inducing effects of Piper extracts in HeLa cells, J Exp Integr Med, 3 (3), pp.225-230. 2013.

[20]      Hidayat, M., Prahastuti, S., Fauziah, N., Maesaroh, Balqis, Widowati, W., Modulation of adipogenesis related gene expression by ethanol extracts of Detam 1 soybean and Jati belanda leaf in 3T3-L1 cells, Banglaesh J Parmaco, 11, pp.697-702. 2016.

[21]      Daheshia M, Yao JQ., The Interleukin 1ß Pathway in the Pathogenesis of Osteoarthritis, J Rheumatol, 35 (12), pp.2306–2312. 2015.

[22]      Blom AB, van Lent PL, Libregts S, Holthuysen AE, van der Kraan PM, van Rooijen N, van den Berg WB., Crucial role of macrophages in matrix metalloproteinase–mediated cartilage destruction during experimental osteoarthritis:Involvement of matrix metalloproteinase 3, Arthritis Rheum, 56 (1), pp.147–157. 2007.

[23]      Goldring MB, Otero M, Plumb DA, Dragomir C, Favero M, Hachim KE, Hashimoto K, Roach HI, Olivotto E, Borzi RM, Marcu KB., Roles of inflammatory and anabolic cytokines in cartilage metabolism: signals and multiple effectors converge upon MMP-13 regulation in osteoarthritis, Eur Cell Mater, 21, pp.202-220. 2011.

[24]      Little CB, Abarai A, Burkhardt D, Smith SM, Fosang AJ, Werb Z, Shah M, Thompson EW., Matrix Metalloproteinase 13–Deficient Mice Are Resistant to Osteoarthritic Cartilage Erosion but Not Chondrocyte Hypertrophy or Osteophyte Development, Arthritis Rheum, 60 (12), pp.3723–3733. 2009.

[25]      Hulejova H, Baresova V, Klezl Z, Polanska M, Adam M, Senolt L., Increased level of cytokines and matrix metalloproteinasesin osteoarthritic subchondral bone, Cytokine, 38 (2007), pp.151–156. 2007.

[26]      Koskinen A, Vuolteenaho K, Nieminen R, Moilanen T, Moilanen E., Leptin enhances MMP-1, MMP-3 and MMP-13 production in human osteoarthritic cartilage and correlates with MMP-1 and MMP-3 in synovial fluid from OA patients, Clin Exp Rheumatol, 29, pp.57-64. 2011.

[27]      Scanzello CR, Umoh E, Pessler F, Diaz-Torne C, Miles T, DiCarlo E, Potter HG, Mandl L, Marx R, Rodeo S, Goldring SR, Crow MK., Local cytokine profiles in knee osteoarthritis: elevated synovial fluid interleukin-15 differentiates early from end-stage disease, OARS, 17 (8), pp.1040–1048. 2009.

[28]      Rowan AD, Young DA., Collagenase gene regulation by pro-inflammatory cytokines in cartilage, Front Biosci, 12, pp.536-550. 2007.

[29]      Gendron C, Kashiwagi M, Hughes C, Caterson B, Nagase H., TIMP-3 inhibits aggrecanase-mediated glycosaminoglycan release from cartilage explants stimulated by catabolic factors, FEBS Lett. 555, pp.431-436. 2003.

[30]      Kashiwagi M, Tortorella M, Nagase H, Brew K., TIMP-3 is a potent inhibitor of aggrecanase 1 (ADAM-TS4) and aggrecanase 2 (ADAM-TS5). J Biol Chem, 276, pp.12501-12504. 2001.

[31]      Moon DO, Kim MO, Choi YH, Park YM, Kim GY., Curcumin attenuates inflammatory response in IL1β-induced human synovial fibroblasts and collagen-induced arthritis in mouse model, Int Immunopharmacol, 10 (5), pp.605–610. 2010.

[32]      Abramson SB, Attur M., Developments in the scientific understanding of osteoarthritis, Arthritis Res Ther, 11, pp.227. 2009.

View my Stats

Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.


ITB Journal Publisher, LPPM ITB, Center for Research and Community Services (CRCS) Building, 6th & 7th Floor, Jalan Ganesha 10, Bandung 40132, Indonesia, Phone: +62-22-86010080, Fax.: +62-22-86010051; E-mail: